A US judge has approved a bankruptcy plan for the maker of OxyContin painkillers, shielding its wealthy owners the Sacklers from further legal action over their roles in America’s opioid epidemic. Under the deal, Purdue Pharma will pay $4.5bn (£3.3bn) to settle lawsuits related to the crisis.
Sackler family wins immunity from further opioid litigation
